Ping An Healthcare and Technology Company Limited (HK:1833)
:1833
Top Page
Ping An Healthcare and Technology Company
(1833)
Select Model
Select Model
Rating:55Neutral
Price Target:
HK$12.00
▼(-2.99% Downside)
Action:ReiteratedDate:03/27/26
The score is mainly supported by improving profitability and cash flow with very low leverage, but is held back by weak technical trend signals (price below all key moving averages and negative MACD) and a high P/E without dividend yield support.
Positive Factors
Very low leverage
Extremely low debt relative to equity and conservative leverage materially reduce financial risk and provide flexibility to invest in product development or M&A. Over 2–6 months this supports resilience to shocks, lowers interest burden, and preserves capacity to fund strategic growth without refinancing stress.
Negative Factors
Revenue volatility
Material top-line swings indicate sensitivity to demand cycles or execution execution gaps. Inconsistent revenue growth complicates forecasting, makes margin sustainability less certain, and raises reliance on margin recovery or ecosystem monetization to sustain earnings over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low leverage
Extremely low debt relative to equity and conservative leverage materially reduce financial risk and provide flexibility to invest in product development or M&A. Over 2–6 months this supports resilience to shocks, lowers interest burden, and preserves capacity to fund strategic growth without refinancing stress.
Read all positive factors
Ping An Healthcare and Technology Company (1833) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$26.74B
Dividend YieldN/A
Average Volume (3M)17.30M
Price to Earnings (P/E)70.4
Beta (1Y)1.26
Revenue Growth14.56%
EPS GrowthN/A
CountryHK
Employees1,563
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.26
Shares Outstanding2,161,443,600
10 Day Avg. Volume8,945,339
30 Day Avg. Volume17,297,252
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)2.62
Price to Sales (P/S)4.89
P/FCF Ratio66.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$17.24Price Target Upside39.37% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)0.22
Revenue Forecast (FY)HK$6.09B
Ping An Healthcare and Technology Company Business Overview & Revenue Model
Company Description
Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in the People's Republic of China. It offers online medical services, such as online consultation, hospital referral...
How the Company Makes Money
Ping An Healthcare and Technology primarily generates revenue through platform-based healthcare services and associated offerings delivered to both individual users and enterprise customers. Key revenue streams include: (1) Online healthcare servi...
Ping An Healthcare and Technology Company Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
82
Very Positive
Cash Flow
60
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.33B | 4.81B | 4.67B | 6.21B | 7.33B |
| Gross Profit | 1.73B | 1.52B | 1.51B | 1.67B | 1.71B |
| EBITDA | 255.49M | 193.43M | -164.23M | -1.05B | -1.76B |
| Net Income | 369.69M | 81.43M | -322.59M | -636.06M | -1.54B |
Balance Sheet | |||||
| Total Assets | 13.24B | 16.78B | 16.52B | 17.14B | 17.88B |
| Cash, Cash Equivalents and Short-Term Investments | 6.97B | 11.52B | 11.35B | 10.14B | 10.14B |
| Total Debt | 39.81M | 45.00M | 93.61M | 176.49M | 201.29M |
| Total Liabilities | 3.33B | 13.20B | 3.25B | 3.68B | 3.79B |
| Stockholders Equity | 9.92B | 3.59B | 13.28B | 13.46B | 14.08B |
Cash Flow | |||||
| Free Cash Flow | 391.83M | 65.08M | -325.82M | -845.05M | -1.49B |
| Operating Cash Flow | 430.72M | 99.33M | -282.86M | -810.62M | -1.40B |
| Investing Cash Flow | 3.04B | 114.65M | -1.49B | 1.71B | -3.10B |
| Financing Cash Flow | -3.84B | -38.44M | -67.36M | -317.88M | -319.91M |
Ping An Healthcare and Technology Company Technical Analysis
Negative
12.37
Price Trends
13.18
Negative
14.05
Negative
14.34
Negative
Market Momentum
-0.35
Negative
45.37
Neutral
33.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1833, the sentiment is Negative. The current price of 12.37 is above the 20-day moving average (MA) of 11.94, below the 50-day MA of 13.18, and below the 200-day MA of 14.34, indicating a bearish trend. The MACD of -0.35 indicates Negative momentum. The RSI at 45.37 is Neutral, neither overbought nor oversold. The STOCH value of 33.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1833.
Ping An Healthcare and Technology Company Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$6.72B | 19.61 | 6.83% | 2.72% | 29.81% | 10.40% | |
66 Neutral | HK$1.46B | 4.60 | 39.78% | 9.92% | -23.31% | -44.61% | |
55 Neutral | HK$26.74B | 70.40 | 3.83% | ― | 14.56% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | HK$5.86B | -110.24 | -2.28% | ― | -4.99% | 47.18% |
* Healthcare Sector Average
HK:1833
Ping An Healthcare and Technology Company
12.37
5.76
87.14%
HK:9886
Dingdang Health Technology Group Ltd.
0.97
0.62
177.14%
HK:1830
Perfect Medical Health Management Limited
1.16
-0.71
-37.97%
HK:2158
Yidu Tech, Inc.
5.50
0.46
9.13%
HK:2192
Medlive Technology Co., Ltd.
9.09
-1.53
-14.41%
HK:2506
Xunfei Healthcare Technology Co., Ltd.
69.75
-40.25
-36.59%
Ping An Healthcare and Technology Company Corporate Events
Ping An Healthcare and Technology Publishes 2025 Audited Annual Results
Mar 24, 2026
Ping An Healthcare and Technology Company Limited has released its audited annual results for the year ended 31 December 2025, fulfilling Hong Kong listing disclosure requirements with a full annual report that includes financial statements, manag...
Ping An Healthcare Sets RMB8.99 Million Cap on 2026 Intra-Group Services Deal
Mar 24, 2026
Ping An Healthcare and Technology’s wholly owned subsidiary Kang Jian has signed a 2026 services purchasing agreement with controlling shareholder Ping An, under which Ping An will continue providing financial, administrative, risk consultin...
Ping An Healthcare Reshapes Board Secretariat With New Company Secretary
Mar 24, 2026
Ping An Healthcare and Technology Company has announced a change in key governance roles, with Cheng Liu stepping down as secretary of the Board, company secretary and authorised representative due to personal work arrangements, effective 24 March...
Ping An Healthcare and Technology Sets March Board Meeting for 2025 Results and Dividend Decision
Mar 2, 2026
Ping An Healthcare and Technology Company Limited has scheduled a board meeting for 24 March 2026 to review and approve the Group’s annual results for the financial year ended 31 December 2025. The board will also consider the declaration of...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.